RxDoctor Payments Data

Fredrick Ogugua

Hospitalist · Plano, TXNPI 1609339902

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,145in general payments, 2019–2025

Across 150 payments — averaging $40.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$646
  • Novartis$643
  • Abiomed$640
  • Medtronic$540
  • Abbott$477
  • Edwards Lifesciences$451
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$5,53190%
  • Education$61310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,145 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$31,177
Ezetimibe12$404
Carvedilol37$225
Atorvastatin Calcium21$212
Amlodipine Besylate32$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$191$31,17726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 hospitalist providers in Texas.

Other hospitalist in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →